ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

CMS Withholds Coverage of CT Colonography

May 15, 2009

No Justification Provided: AAUP Demands Reinstatement of Faculty Denied Tenure Renewal at MD Anderson

May 16, 2014

Fountain Displays Some Statesmanship

July 8, 1977

New GAO Report Critical Of federal Effort Against Environmental Carcinogenesis

June 25, 1976

DRCCA Board Votes To Pull NCI Out Of Joint Program With OSHA For Workplace Education And Prevention

January 29, 1982

Center Directors To Hear “Creative” Approach to Funding Cancer Control

February 25, 1983